DD115659A5 - - Google Patents

Info

Publication number
DD115659A5
DD115659A5 DD182648A DD18264874A DD115659A5 DD 115659 A5 DD115659 A5 DD 115659A5 DD 182648 A DD182648 A DD 182648A DD 18264874 A DD18264874 A DD 18264874A DD 115659 A5 DD115659 A5 DD 115659A5
Authority
DD
German Democratic Republic
Application number
DD182648A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2360443A external-priority patent/DE2360443A1/de
Priority claimed from DE19742445161 external-priority patent/DE2445161A1/de
Application filed filed Critical
Publication of DD115659A5 publication Critical patent/DD115659A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
DD182648A 1973-11-30 1974-11-28 DD115659A5 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2360443A DE2360443A1 (de) 1973-11-30 1973-11-30 D-homo-20-ketopregnane
DE19742445161 DE2445161A1 (de) 1974-09-19 1974-09-19 D-homo-20-ketopregnane ii

Publications (1)

Publication Number Publication Date
DD115659A5 true DD115659A5 (https=) 1975-10-12

Family

ID=25766200

Family Applications (1)

Application Number Title Priority Date Filing Date
DD182648A DD115659A5 (https=) 1973-11-30 1974-11-28

Country Status (14)

Country Link
US (1) US4045574A (https=)
JP (1) JPS5084561A (https=)
AT (1) AT347611B (https=)
CA (1) CA1030522A (https=)
CH (1) CH618183A5 (https=)
DD (1) DD115659A5 (https=)
DK (1) DK134348C (https=)
ES (1) ES432106A1 (https=)
FR (1) FR2253512B1 (https=)
GB (1) GB1494097A (https=)
IE (1) IE40423B1 (https=)
IL (1) IL46153A (https=)
NL (1) NL7415577A (https=)
SE (1) SE408426B (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879316A (en) * 1987-02-26 1989-11-07 The University Of Tennessee Research Corporation Interpenetrating polymer network ion exchange membranes and method for preparing same
US6787530B1 (en) 1996-08-23 2004-09-07 Monash University Use of pregnane-diones as analgesic agents
US20040034215A1 (en) * 2002-08-16 2004-02-19 White Michael J. 5-Androsten-3beta-ol steroid intermediates and processes for their preparation
US20070066579A1 (en) * 2002-08-16 2007-03-22 White Michael J 5-androsten-3beta-ol steroid intermediates and processs for their preparation
US20160068563A1 (en) 2013-04-17 2016-03-10 Boyd L. Harrison 19-nor neuroactive steroids and methods of use thereof
KR102396328B1 (ko) 2013-04-17 2022-05-10 세이지 테라퓨틱스, 인크. 19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법
EP2986624B1 (en) 2013-04-17 2020-03-25 Sage Therapeutics, Inc. 19-nor neuroactive steroids for methods of treatment
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
SI3021852T1 (sl) 2013-07-19 2021-07-30 Sage Therapeutics, Inc. Nevroaktivni steroidi, sestavki in uporabe le-teh
AU2014308621C1 (en) 2013-08-23 2022-01-06 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
CN117024501A (zh) 2014-10-16 2023-11-10 萨奇治疗股份有限公司 靶向cns障碍的组合物和方法
ME03809B (me) 2014-10-16 2021-04-20 Sage Therapeutics Inc KOMPOZICIJE I POSTUPCI ZA LEČENJE POREMEĆAJA CNS-a
WO2016082789A1 (en) 2014-11-27 2016-06-02 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
RS61530B1 (sr) 2015-01-26 2021-04-29 Sage Therapeutics Inc Kompozicije i postupci za lečenje poremećaja cns
EP4155314A1 (en) 2015-02-20 2023-03-29 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
MA45599A (fr) 2016-07-11 2019-05-15 Sage Therapeutics Inc Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation
WO2018013615A1 (en) 2016-07-11 2018-01-18 Sage Therapeutics, Inc. C7, c12, and c16 substituted neuroactive steroids and their methods of use
BR112020012761A2 (pt) * 2017-12-22 2021-02-17 Sage Therapeutics, Inc. composições e métodos para o tratamento de distúrbios do snc
KR20250174100A (ko) 2018-12-05 2025-12-11 세이지 테라퓨틱스, 인크. 신경활성 스테로이드 및 이의 사용 방법
CN115651054B (zh) 2019-01-08 2024-06-21 成都康弘药业集团股份有限公司 甾体类化合物、用途及其制备方法
SG11202112391UA (en) 2019-05-31 2021-12-30 Sage Therapeutics Inc Neuroactive steroids and compositions thereof
JP7754725B2 (ja) * 2019-06-27 2025-10-15 セージ セラピューティクス, インコーポレイテッド Cns障害を治療するための組成物及び方法
CA3143509A1 (en) 2019-06-27 2020-12-30 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
CN114729000A (zh) * 2019-06-27 2022-07-08 萨奇治疗股份有限公司 用于治疗cns病症的化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2860158A (en) * 1954-10-18 1958-11-11 Sterling Drug Inc Compounds of the perhydrochrysene series and preparation thereof
US3686223A (en) * 1968-12-26 1972-08-22 Sterling Drug Inc D-homoestratrienes
US3833621A (en) * 1972-03-20 1974-09-03 Richardson Merrell Inc 3-keto-7(alpha,beta)-loweralkyl-delta5 steroids and process for preparing same

Also Published As

Publication number Publication date
DK134348B (da) 1976-10-25
SE7414960L (https=) 1975-06-02
CH618183A5 (https=) 1980-07-15
DK604174A (https=) 1975-07-28
CA1030522A (en) 1978-05-02
AU7586774A (en) 1976-06-03
JPS5084561A (https=) 1975-07-08
DK134348C (da) 1977-03-21
FR2253512B1 (https=) 1978-02-03
SE408426B (sv) 1979-06-11
FR2253512A1 (https=) 1975-07-04
ES432106A1 (es) 1976-11-01
IE40423L (en) 1975-05-30
ATA950774A (de) 1978-05-15
IL46153A0 (en) 1975-02-10
IE40423B1 (en) 1979-05-23
AT347611B (de) 1979-01-10
NL7415577A (nl) 1975-06-03
GB1494097A (en) 1977-12-07
US4045574A (en) 1977-08-30
IL46153A (en) 1979-01-31

Similar Documents

Publication Publication Date Title
AR201758A1 (https=)
AU465372B2 (https=)
AR201235Q (https=)
AR201231Q (https=)
AU474593B2 (https=)
AU474511B2 (https=)
FR2253512B1 (https=)
AU474838B2 (https=)
AU471343B2 (https=)
AU465453B2 (https=)
AU465434B2 (https=)
AU450229B2 (https=)
AU476714B2 (https=)
AR201229Q (https=)
AU472848B2 (https=)
AU466283B2 (https=)
AR199451A1 (https=)
AU476696B2 (https=)
AR196382A1 (https=)
AU447540B2 (https=)
AR197627A1 (https=)
AR200256A1 (https=)
AR200885A1 (https=)
AR210729A1 (https=)
AU461342B2 (https=)